The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • How to interpret clinical trial results for Long COVID

    How to interpret clinical trial results for Long COVID

    Simon Spichak

    With no proven treatments or cures, many people with Long COVID are turning to off-label medications, supplements, and medical devices to treat their symptoms. There are numerous options — and some of them even have clinical trials underway or are reporting results. But even if one study suggests a treatment might work, another might contradict it. Read more…

Recent articles

  • Research updates, July 21
    Science
    Miles W. Griffis

    Research updates, July 21

  • National COVID-19 trends, July 21
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, July 21

  • Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peers
    Commentary, International
    Whitney Fox

    Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peers

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersAbandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersWhitney Fox
What can professional athletes teach us about Long COVID and rest?What can professional athletes teach us about Long COVID and rest?Melanie Marich
How to interpret clinical trial results for Long COVIDHow to interpret clinical trial results for Long COVIDSimon Spichak
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
National COVID-19 trends, July 14National COVID-19 trends, July 14Betsy Ladyzhets

Policy & Advocacy

Science

  • November 14, 2023

    What’s happening this week, November 14

Previous Page
1 … 35 36 37

Covid-19

Health

Commentary

  • October 10, 2025

    Vyvgart brought us back to life, but the Long COVID trial was canceled. We are calling on the NIH and HHS to study the drug.

  • October 3, 2025

    Long COVID inspired me to start an IACC case competition at my business school. Here’s how you can get involved.

  • September 30, 2025

    Patricia Lockwood explores the depths of Long COVID in the new novel “Will There Ever Be Another You”

  • September 23, 2025

    Letter to the editors: Concerns about California’s right-to-mask bill

Previous Page
1 … 6 7 8 9 10 … 25
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...